The Role of Neoadjuvant Trials in Drug Development for Solid Tumors

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-15-1961
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Correction: Neoadjuvant Trials in ER+ Breast Cancer: A Tool for Acceleration of Drug Development and Discovery

Cancer Discovery
Oncology
2019English

Role of microRNA-150 in Solid Tumors (Review)

Oncology Letters
Cancer ResearchOncology
2015English

High‐Dose Chemotherapy in Adult Solid Tumors and Lymphoproliferative Disorders: The Need for Randomized Trials

Oncologist
Cancer ResearchMedicineOncology
1997English

Use of Biomarkers in ALS Drug Development and Clinical Trials

Brain Research
NeuroscienceNeurologyDevelopmental BiologyMolecular Biology
2015English

Challenges for the Clinical Development of PI3K Inhibitors: Strategies to Improve Their Impact in Solid Tumors

Cancer Discovery
Oncology
2019English

Role of High Resolution Sonography in Characterization of Solid Salivary Gland Tumors

Journal of Evolution of Medical and Dental Sciences
2015English

Onivyde for the Therapy of Multiple Solid Tumors

OncoTargets and Therapy
OncologyPharmacology
2016English

Do FHIT Gene Alterations Play a Role in Human Solid Tumors?

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2018English

Role of Neuroimaging in Analgesic Drug Development

Drugs in R and D
Pharmacology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy